GoHealth
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GoHealth generated cash of $109,141,000, which is more than the previous year. Cash used in financing activities reached the amount of -$21,106,000 last year. Net change in cash is therefore $74,345,000.
Cash Flow
| 2018 | 5.44M | -6.17M | 63K |
|---|---|---|---|
| 2019 | -3K | -815.60M | 827.43M |
| 2020 | -114.21M | -14.52M | 260.66M |
| 2021 | -299.00M | -19.80M | 259.08M |
| 2022 | 60.90M | -13.51M | -115.05M |
| 2023 | 109.14M | -13.73M | -21.10M |
GOCO Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 16.46M | 84.36M | 144.23M | 12.27M | 505K | 1.17M |
Operating activities | ||||||
Net income | -151.27M | -376.38M | -534.19M | -97.2M | -41.06M | 28.11M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 105.74M | 107.00M | 107.50M | 98.55M | 32.98M | 6.16M |
Stock-based compensation expense | 19.54M | 27.14M | 27.29M | 216.22M | 0 | 0 |
| Deferred income tax benefit | 19.54M | 27.14M | 27.29M | 216.22M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 125.09M | 243.84M | -455.70M | -429.11M | -282.62M | -64.70M |
Inventories | 0 | 0 | 1.52M | -10.88M | 11.61M | 957K |
Accounts payable | 2.55M | -28.21M | 147.96M | 102.24M | 3.05M | 34.00M |
Cash generated by operating activities | 109.14M | 60.90M | -299.00M | -114.21M | -3K | 5.44M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | -508.32M | 0 | 0 |
Investments In Property Plant And Equipment | -13.73M | -13.51M | -19.80M | -14.52M | -8.01M | -6.17M |
Acquisitions Net | 0 | 0 | 0 | 0 | -807.59M | 0 |
Cash generated by investing activities | -13.73M | -13.51M | -19.80M | -14.52M | -815.60M | -6.17M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 862.40M | 541.26M | 0 |
Payments for dividends | -3.56M | 0 | 0 | -400K | 0 | 0 |
Repurchases of common stock | -2.29M | -345K | 0 | -100M | 541.26M | 0 |
Repayments of term debt | -15.33M | -160.27M | -299.28M | -4.17M | 286.16M | -82.41M |
Cash used in financing activities | -21.10M | -115.05M | 259.08M | 260.66M | 827.43M | 63K |
Net Change In Cash | 74.34M | -67.89M | -59.87M | 131.95M | 11.77M | -667K |
Cash at end of period | 90.80M | 16.46M | 84.36M | 144.23M | 12.27M | 505K |
| Data source | Data source | Data source | Data source |